Fabtech Technologies Limited was incorporated as a Private Company as 'Globeroute Ventures Private Limited' dated October 26, 2018 issued by the Registrar of Companies, Central Registration Centre. Subsequently, the name of the Company was changed to 'Fabtech Technologies Private Limited' vide fresh Certificate of Incorporation dated January 21, 2021. Further, the status was converted into a Public Company and renamed to 'Fabtech Technologies Limited', w.e.f. July 24, 2024, issued by the Central Processing Centre.
The Company is a key turnkey engineering solution provider in pharmaceuticals capex space, offering comprehensive start to finish solutions encompassing designing, engineering, procurement, installation and testing of pharmaceutical equipment for a wide range of customers.
In 2020, the Export Division of Fabtech Technologies International Private Limited (FTIPL), under which it executed turnkey pharmaceutical engineering projects, was demerged into the Company through Scheme of Amalgamation. Further, the entire shareholding also got transferred from FTIPL to shareholders of FTIPL, by virtue of which Aasif Ahsan Khan, Hemant Mohan Anavkar Aarif Ahsan Khan and Manisha Hemant Anavkar became the Promoters of the Company in 2020.
The Company completed a a turnkey project for a state-owned organization in Bangladesh, involving installation of 172 clean room doors across designated buildings in 2022. It completed installation of process equipment, such as isolators, tablet compression equipment, and related infrastructure for a pharmaceutical manufacturer in Algeria in 2023. Further, completed procurement, implementation of facilities and monitoring of cleanrooms installation work for a facility to manufacture oral solid dosage, liquid oral dosage, disinfectant and penicillin secondary packaging area in Kingdom of Saudi Arabia.
In 2024, the Company acquired FT Institutions Private Limited from FTIPL by executing turnkey pharmaceutical engineering pr